tumor

Three blocks displaying from left to right a person a handshake and another person
Biotech

Merck KGaA pays $85M for global rights to Abbisko's tumor drug

With the CSF-1R inhibitor space heating up, Germany's Merck has gone all-in on pimicotinib, paying Abbisko $85 million for the global license.
James Waldron Apr 1, 2025 7:40am
Abstract 3D Geometric Shapes Cube Blocks Background

Takeda's oncology execs sharpen focus after restructuring

Mar 13, 2025 10:59am
Graphic image of a fishing line looking to hook onto 100 bills underwater

Merck KGaA tacks on Abbisko’s joint tumor med for $70M upfront

Dec 4, 2023 10:26am
An arrow incrementally going up stairs before pointing straight up Blue background

Deciphera's tumor-tackling oral med achieves 40% response rate

Oct 30, 2023 11:00am
Zurich Switzerland

Racing Sanofi, ImmunOs bags $74M for myeloid checkpoint trials

Jun 7, 2022 8:30am
Novartis

Novartis tags Molecular Partners for $580M radioligand deal

Dec 14, 2021 10:34am